These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 23636235

  • 1. Weight change at 1 mo of antiretroviral therapy and its association with subsequent mortality, morbidity, and CD4 T cell reconstitution in a Tanzanian HIV-infected adult cohort.
    Sudfeld CR, Isanaka S, Mugusi FM, Aboud S, Wang M, Chalamilla GE, Giovannucci EL, Fawzi WW.
    Am J Clin Nutr; 2013 Jun; 97(6):1278-87. PubMed ID: 23636235
    [Abstract] [Full Text] [Related]

  • 2. Effect of high-dose vs standard-dose multivitamin supplementation at the initiation of HAART on HIV disease progression and mortality in Tanzania: a randomized controlled trial.
    Isanaka S, Mugusi F, Hawkins C, Spiegelman D, Okuma J, Aboud S, Guerino C, Fawzi WW.
    JAMA; 2012 Oct 17; 308(15):1535-44. PubMed ID: 23073950
    [Abstract] [Full Text] [Related]

  • 3. Association of serum albumin concentration with mortality, morbidity, CD4 T-cell reconstitution among tanzanians initiating antiretroviral therapy.
    Sudfeld CR, Isanaka S, Aboud S, Mugusi FM, Wang M, Chalamilla GE, Fawzi WW.
    J Infect Dis; 2013 May 01; 207(9):1370-8. PubMed ID: 23319741
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of vitamin D3 supplementation in reducing incidence of pulmonary tuberculosis and mortality among HIV-infected Tanzanian adults initiating antiretroviral therapy: study protocol for a randomized controlled trial.
    Sudfeld CR, Mugusi F, Aboud S, Nagu TJ, Wang M, Fawzi WW.
    Trials; 2017 Feb 10; 18(1):66. PubMed ID: 28183335
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapy.
    Sudfeld CR, Wang M, Aboud S, Giovannucci EL, Mugusi FM, Fawzi WW.
    PLoS One; 2012 Feb 10; 7(6):e40036. PubMed ID: 22768212
    [Abstract] [Full Text] [Related]

  • 6. Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-infected Tanzanian adults initiating antiretroviral therapy.
    Sudfeld CR, Giovannucci EL, Isanaka S, Aboud S, Mugusi FM, Wang M, Chalamilla G, Fawzi WW.
    J Infect Dis; 2013 Feb 01; 207(3):378-85. PubMed ID: 23162137
    [Abstract] [Full Text] [Related]

  • 7. Cholecalciferol Supplementation Does Not Affect the Risk of HIV Progression, Viral Suppression, Comorbidities, Weight Loss, and Depression among Tanzanian Adults Initiating Antiretroviral Therapy: Secondary Outcomes of a Randomized Trial.
    Muhihi A, Fawzi WW, Aboud S, Nagu TJ, Ulenga N, Wang M, Mugusi F, Sudfeld CR.
    J Nutr; 2022 Aug 09; 152(8):1983-1990. PubMed ID: 35460249
    [Abstract] [Full Text] [Related]

  • 8. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis.
    Ravimohan S, Tamuhla N, Steenhoff AP, Letlhogile R, Makutu DK, Nfanyana K, Rantleru T, Tierney A, Nkakana K, Schwartz AB, Gross R, Macgregor RR, Bellamy SL, Frank I, Weissman D, Bisson GP.
    J Infect Dis; 2013 Dec 01; 208(11):1784-93. PubMed ID: 23908475
    [Abstract] [Full Text] [Related]

  • 9. Predictive effects of body mass index on immune reconstitution among HIV-infected HAART users in China.
    Li X, Ding H, Geng W, Liu J, Jiang Y, Xu J, Zhang Z, Shang H.
    BMC Infect Dis; 2019 May 02; 19(1):373. PubMed ID: 31046702
    [Abstract] [Full Text] [Related]

  • 10. Effects on mortality of a nutritional intervention for malnourished HIV-infected adults referred for antiretroviral therapy: a randomised controlled trial.
    NUSTART (Nutritional Support for Africans Starting Antiretroviral Therapy) Study Team, Filteau S, PrayGod G, Kasonka L, Woodd S, Rehman AM, Chisenga M, Siame J, Koethe JR, Changalucha J, Michael D, Kidola J, Manno D, Larke N, Yilma D, Heimburger DC, Friis H, Kelly P.
    BMC Med; 2015 Jan 28; 13():17. PubMed ID: 25630368
    [Abstract] [Full Text] [Related]

  • 11. An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy.
    Koethe JR, Jenkins CA, Shepherd BE, Stinnette SE, Sterling TR.
    Clin Infect Dis; 2011 Nov 28; 53(9):952-60. PubMed ID: 21946189
    [Abstract] [Full Text] [Related]

  • 12. Depression at antiretroviral therapy initiation and clinical outcomes among a cohort of Tanzanian women living with HIV.
    Sudfeld CR, Kaaya S, Gunaratna NS, Mugusi F, Fawzi WW, Aboud S, Smith Fawzi MC.
    AIDS; 2017 Jan 14; 31(2):263-271. PubMed ID: 27835614
    [Abstract] [Full Text] [Related]

  • 13. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
    Liu E, Makubi A, Drain P, Spiegelman D, Sando D, Li N, Chalamilla G, Sudfeld CR, Hertzmark E, Fawzi WW.
    AIDS; 2015 Jul 17; 29(11):1391-9. PubMed ID: 26091295
    [Abstract] [Full Text] [Related]

  • 14. Body mass index, proteinuria and total lymphocyte counts in predicting treatment responses among ART naïve individuals with HIV initiated on antiretroviral treatment in Dar es Salaam, Tanzania, 2019: a cohort study.
    Munseri P, Jassely L, Tumaini B, Hertzmark E.
    BMJ Open; 2022 Jun 08; 12(6):e059193. PubMed ID: 35676009
    [Abstract] [Full Text] [Related]

  • 15. Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.
    Molina JM, Grund B, Gordin F, Williams I, Schechter M, Losso M, Law M, Ekong E, Mwelase N, Skoutelis A, Wiselka MJ, Vandekerckhove L, Benfield T, Munroe D, Lundgren JD, Neaton JD, INSIGHT START study group.
    Lancet HIV; 2018 Apr 08; 5(4):e172-e180. PubMed ID: 29352723
    [Abstract] [Full Text] [Related]

  • 16. Micronutrient supplementation in adults with HIV infection.
    Visser ME, Durao S, Sinclair D, Irlam JH, Siegfried N.
    Cochrane Database Syst Rev; 2017 May 18; 5(5):CD003650. PubMed ID: 28518221
    [Abstract] [Full Text] [Related]

  • 17. Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.
    Hermans SM, Manabe YC, Kiragga AN, Hoepelman AI, Lange JM, van Leth F.
    Antivir Ther; 2013 May 18; 18(4):615-22. PubMed ID: 23423604
    [Abstract] [Full Text] [Related]

  • 18. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.
    Pediatrics; 2002 Feb 18; 109(2):E25. PubMed ID: 11826235
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of hepatitis B co-infection and response to antiretroviral therapy among HIV-infected patients in Tanzania.
    Hawkins C, Christian B, Ye J, Nagu T, Aris E, Chalamilla G, Spiegelman D, Mugusi F, Mehta S, Fawzi W.
    AIDS; 2013 Mar 27; 27(6):919-927. PubMed ID: 23196935
    [Abstract] [Full Text] [Related]

  • 20. Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study.
    Nsanzimana S, Remera E, Kanters S, Forrest JI, Ford N, Condo J, Binagwaho A, Bucher H, Thorlund K, Vitoria M, Mills EJ.
    Lancet HIV; 2015 Sep 27; 2(9):e376-84. PubMed ID: 26423551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.